Agilent Technologies (NYSE:A) Updates Q3 2026 Earnings Guidance

Agilent Technologies (NYSE:A) updated its third quarter 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.480-1.500 for the period, compared to the consensus earnings per share estimate of 1.500. The company issued revenue guidance of $1.8 billion-$1.9 billion, compared to the consensus revenue estimate of $1.8 billion. Agilent Technologies also updated its FY 2026 guidance to 6.000-6.100 EPS.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on A. Barclays decreased their price target on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Wells Fargo & Company decreased their price target on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research report on Thursday, February 26th. TD Cowen decreased their price target on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. UBS Group reduced their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Finally, Morgan Stanley reduced their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Two research analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, Agilent Technologies currently has a consensus rating of “Buy” and an average price target of $162.40.

Agilent Technologies Trading Up 0.6%

Shares of Agilent Technologies stock traded up $0.74 during trading on Wednesday, hitting $115.82. The stock had a trading volume of 2,899,904 shares, compared to its average volume of 2,183,498. The firm’s fifty day simple moving average is $114.91 and its 200-day simple moving average is $129.01. The stock has a market cap of $32.73 billion, a PE ratio of 25.57, a PEG ratio of 2.42 and a beta of 1.22. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. Agilent Technologies has a 12 month low of $108.35 and a 12 month high of $160.27.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.09. The firm had revenue of $1.84 billion during the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, sell-side analysts expect that Agilent Technologies will post 5.95 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is 22.52%.

Key Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent raised its FY 2026 outlook, guiding for EPS of $6.00-$6.10 and revenue of $7.4 billion-$7.5 billion, both in line to slightly above Wall Street expectations. The company also guided Q3 EPS to $1.48-$1.50 on revenue of $1.8 billion-$1.9 billion, signaling stable demand and execution.
• Positive Sentiment: Royal Bank of Canada initiated/started coverage with an Outperform rating and a $153 price target, implying meaningful upside from current levels. Benzinga
• Positive Sentiment: Robert W. Baird also raised its price target to $156 and reiterated an Outperform rating, reinforcing analyst confidence ahead of the next earnings cycle. Benzinga
• Neutral Sentiment: Recent product and conference announcements, including new GC systems, a MAM solution for biopharma quality control, and cancer research showcases, highlight ongoing innovation but are less likely to move the stock immediately.

Institutional Investors Weigh In On Agilent Technologies

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Sivia Capital Partners LLC bought a new stake in shares of Agilent Technologies in the 2nd quarter valued at about $273,000. Brighton Jones LLC increased its stake in Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares in the last quarter. SmartHarvest Portfolios LLC acquired a new position in Agilent Technologies during the 4th quarter valued at approximately $203,000. IFC & Insurance Marketing Inc. acquired a new position in Agilent Technologies during the 4th quarter valued at approximately $155,000. Finally, Zions Bancorporation National Association UT increased its stake in Agilent Technologies by 17.2% during the 4th quarter. Zions Bancorporation National Association UT now owns 990 shares of the medical research company’s stock valued at $135,000 after purchasing an additional 145 shares in the last quarter. Institutional investors own 87.41% of the company’s stock.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.